Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AKT inhibition in solid tumors with AKT1 mutations
    Journal Article

    Hyman, D. M.; Smyth, L. M.; Donoghue, M. T. A.; Westin, S. N.; Bedard, P. L.; Dean, E. J.; Bando, H.; El-Khoueiry, A. B.; PeĢrez-Fidalgo, J. A.; Mita, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Reply to B. Rini et al and S. Buti et al
    Journal Article

    Choueiri, T. K.; Halabi, S.; Morris, M. J.; George, D.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study
    Journal Article

    Tomita, Y.; Fukasawa, S.; Shinohara, N.; Kitamura, H.; Oya, M.; Eto, M.; Tanabe, K.; Kimura, G.; Yonese, J.; Yao, M.; more...
    Japanese Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Cardiovascular complications of androgen deprivation therapy for prostate cancer
    Journal Article

    Gupta, D.; Salmane, C.; Slovin, S.; Steingart, R. M.
    Current Treatment Options in Cardiovascular Medicine (2017)

    Fulltext@MSK | Save
  • Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity
    Journal Article

    Wheeler, H. E.; Gamazon, E. R.; Frisina, R. D.; Perez-Cervantes, C.; El Charif, O.; Mapes, B.; Fossa, S. D.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone
    Journal Article

    Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R. F.; Alumkal, J. J.; Ryan, C. J.; Saleh, M.; Hauke, R. J.; Bandekar, R.; Maneval, E. C.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • The DART Study: Results from the dose-escalation and expansion cohorts evaluating the combination of dalantercept plus axitinib in advanced renal cell carcinoma
    Journal Article

    Voss, M. H.; Bhatt, R. S.; Plimack, E. R.; Rini, B. I.; Alter, R. S.; Beck, J. T.; Wilson, D.; Zhang, X.; Mutyaba, M.; Glasser, C.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • ETV1-positive cells give rise to BRAF(V600E)-mutant gastrointestinal stromal tumors
    Journal Article

    Ran, L.; Murphy, D.; Sher, J.; Cao, Z.; Wang, S.; Walczak, E.; Guan, Y.; Xie, Y.; Shukla, S.; Zhan, Y.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
    Journal Article

    Knox, J. J.; Barrios, C. H.; Kim, T. M.; Cosgriff, T.; Srimuninnimit, V.; Pittman, K.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R. D.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer
    Journal Article

    Hammerich, K. H.; Donahue, T. F.; Rosner, I. L.; Cullen, J.; Kuo, H. C.; Hurwitz, L.; Chen, Y.; Bernstein, M.; Coleman, J.; Danila, D. C.; more...
    Urologic Oncology: Seminars and Original Investigations (2017)

    Fulltext@MSK | Save